The present invention relates to pyridopyrimidine derivatives according toformula (I), as autotaxin inhibitors andthe use of such compounds for the treatment and/or prophylaxis ofphysiological and/or pathophysiological conditions, which arecaused, mediated and/or propagated by increased lysophosphatic acid levelsand/or the activation of autotaxin, in particular ofdifferent cancers.